Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq

Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq

Source: 
BioSpace
snippet: 

Two years ago, Cerevel Therapeutics spun out of Pfizer. It then took an unusual approach, merging with a special purpose acquisition company, Arya Sciences Acquisition Corp II. Arya was designed specifically to acquire or merge with another company.